The death-inducing cytokine tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) holds enormous promise as an anti-cancer agent due to its highly selective apoptosis-inducing action on neoplastic versus normal cells [6,7]. This evidence concerns the gene TNFSF10 and cancer.